Actionnariat et activité des initiés pour Bioventus Inc. (BVS): transactions des initiés, déclarations de trading du Sénat et de la Chambre américaine et actions en circulation. Suivez comment dirigeants et politiciens négocient le titre.
Prix
| Prix | $13.20 |
| Capitalisation | $894M |
| Bourse | NASDAQ |
| Pays | US |
Transactions d'Initiés Récentes
| Date | Initié | Type | Actions | Valeur |
|---|---|---|---|---|
| 2026-06-02 | Bartholdson John A. | M-Exempt | 32,282 | |
| 2026-06-03 | Bartholdson John A. | A-Award | 25,146 | |
| 2026-06-02 | Bartholdson John A. | M-Exempt | 32,282 | |
| 2026-06-02 | SUTTER MARTIN P | M-Exempt | 32,282 | |
| 2026-06-03 | SUTTER MARTIN P | A-Award | 25,146 | |
| 2026-06-02 | SUTTER MARTIN P | M-Exempt | 32,282 | |
| 2026-06-02 | STALNECKER SUSAN M | M-Exempt | 32,282 | |
| 2026-06-03 | STALNECKER SUSAN M | A-Award | 25,146 | |
| 2026-06-02 | STALNECKER SUSAN M | M-Exempt | 32,282 | |
| 2026-06-02 | NOHRA GUY P | M-Exempt | 32,282 |
Bilan (10 ans)
| Année | 2014 | 2015 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Trésorerie | $15.8M | $5.0M | $42.8M | $64.5M | $86.8M | $43.9M | $30.2M | $37.0M | $41.6M | $51.2M |
| Placements à Court Terme | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Créances | $47.1M | $54.5M | $73.0M | $85.1M | $88.3M | $125.0M | $136.3M | $122.8M | $127.4M | $128.3M |
| Stocks | $26.7M | $35.2M | $27.4M | $27.3M | $29.1M | $61.7M | $84.8M | $91.3M | $92.5M | $82.2M |
| Actifs Courants | $95.2M | $99.4M | $148.4M | $183.0M | $211.8M | $263.1M | $272.6M | $268.0M | $275.6M | $272.8M |
| Immobilisations Corporelles | $10.4M | $9.6M | $4.8M | $19.8M | $21.8M | $40.2M | $44.1M | $50.0M | $33.5M | $27.0M |
| Goodwill | $50.0M | $58.7M | $49.8M | $49.8M | $49.8M | $147.6M | $7.5M | $7.5M | $7.5M | $7.5M |
| Actifs Incorporels | $274.3M | $319.2M | $237.0M | $216.5M | $191.7M | $695.2M | $639.9M | $482.4M | $404.7M | $368.4M |
| Actifs Totaux | $430.4M | $487.4M | $442.7M | $472.4M | $494.5M | $1.23B | $1.37B | $810.9M | $728.0M | $683.6M |
| Dettes Fournisseurs | $5.4M | $8.4M | $8.2M | $6.4M | $4.4M | $16.9M | $36.7M | $23.0M | $23.7M | $10.9M |
| Dette à Court Terme | $7.2M | $36.5M | $5.2M | $10.0M | $15.0M | $18.0M | $33.1M | $27.8M | $27.3M | $19.2M |
| Passifs Courants | $52.2M | $87.7M | $65.4M | $89.0M | $122.6M | $180.9M | $304.0M | $175.5M | $210.4M | $160.4M |
| Dette à Long Terme | $162.3M | $157.6M | $189.6M | $188.0M | $173.4M | $339.6M | $385.0M | $367.0M | $308.3M | $279.0M |
| Passifs Totaux | $252.9M | $295.0M | $297.5M | $326.8M | $350.3M | $692.1M | $960.4M | $589.8M | $542.4M | $455.1M |
| Réserves | -$56.5M | -$91.8M | -$139.8M | -$141.7M | -$144.5M | -$6.6M | -$165.3M | -$321.5M | -$355.1M | -$334.9M |
| Capitaux Propres | $177.5M | $192.3M | $145.3M | $143.0M | $142.2M | $458.9M | $325.2M | $173.6M | $147.9M | $184.1M |
| Dette Totale | $171.0M | $196.5M | $194.8M | $198.0M | $188.4M | $357.7M | $418.1M | $394.8M | $335.6M | $311.3M |
| Dette Nette | $155.2M | $191.6M | $152.1M | $133.4M | $101.5M | $313.7M | $387.9M | $357.9M | $294.0M | $260.1M |
| Fonds de Roulement | $43.1M | $11.7M | $82.9M | $94.0M | $89.2M | $82.2M | -$31.4M | $92.5M | $65.2M | $112.5M |
Santé financière
| Dette / Capitaux propres | 1.16 |
| Ratio de liquidité | 1.69 |
| Piotroski F-Score | 7 |
| Altman Z-Score | 1.28 |
Rentabilité
| Rentabilité des capitaux propres | 28.39% |
| Rentabilité du capital investi | 11.37% |
| Rentabilité des actifs | 8.09% |
| Marge brute | 68.00% |
| Marge opérationnelle | 10.63% |
| Marge nette | 9.36% |
Entreprises liées: AVNS · BFLY · CBLL · CTKB · KIDS · LAB · SMLR
Explorer le secteur: Healthcare · Medical - Devices
Plus de sections de BVS: Vue d'ensemble · Financiers · Valorisation · Statistiques · Estimations · Technique · Actualités · Événements
Découvrir plus: Radar — signaux d'actions sous-évaluées · Académie d'Investissement — apprenez à analyser les actions